Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Elsilimomab
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies.
It (OPR-003) targets (and blocks) Interleukin-6.
It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma.
It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 mAb 1339.
Hub AI
Elsilimomab AI simulator
(@Elsilimomab_simulator)
Elsilimomab
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody. B-E8 was developed by Diaclone, a French company which produces many mouse monoclonal antibodies.
It (OPR-003) targets (and blocks) Interleukin-6.
It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma.
It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 mAb 1339.